Cargando…

Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism

Detalles Bibliográficos
Autores principales:	Reynolds, Miriam, Clem, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072974/ http://dx.doi.org/10.1186/2049-3002-2-S1-P61

Ejemplares similares

Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
por: Rashid-Kolvear, Fariborz, et al.
Publicado: (2010)

Control of Glutamine Metabolism By the Tumor Suppressor Rb
por: Reynolds, Miriam R., et al.
Publicado: (2013)

RB in glutamine metabolism
por: Clem, Brian
Publicado: (2014)

Inhibition of glutamine uptake regulates mTORC1, glutamine metabolism and cell growth in prostate cancer
por: Wang, Qian, et al.
Publicado: (2014)

Assessment of troglitazone induced liver toxicity in a dynamically perfused two-organ Micro-Bioreactor system
por: Materne, Eva-Maria, et al.
Publicado: (2013)

Troglitazone Attenuates TGF-β1-Induced EMT in Alveolar Epithelial Cells via a PPARγ-Independent Mechanism
por: Zhou, Beiyun, et al.
Publicado: (2012)

Investigation of glutamine metabolism in CHO cells by dynamic metabolic flux analysis
por: Wahrheit, Judith, et al.
Publicado: (2013)

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
por: Tsai, Jaw-Shiun, et al.
Publicado: (2014)

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells
por: Bolden, Adrienne, et al.
Publicado: (2012)

Pancreatic cancers depend on a non-canonical glutamine metabolism pathway
por: Lyssiotis, Costas, et al.
Publicado: (2014)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells
por: Cheng, Huey-Chuan, et al.
Publicado: (2008)

Short treatment of metformin attenuated insulin resistance and hepatic steatosis in obese mice by mechanisms independents of PPAR-alpha
por: Teixeira, Alexandre, et al.
Publicado: (2014)

Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
por: Souza, Camila O, et al.
Publicado: (2014)

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Exercise suppresses tumor growth through epinephrine- and IL-6-dependent mobilization and redistribution of NK cells
por: Pedersen, Line, et al.
Publicado: (2015)

PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux
por: Nazim, Uddin MD., et al.
Publicado: (2017)

Is a combined i.v. and enteral glutamine regimen superior to a single i.v. glutamine regimen in severe thoracic trauma?
por: Pavelescu, D, et al.
Publicado: (2013)

Egr-1 mediates the suppressive effect of IL-1 on PPARγ expression in human OA chondrocytes
por: Nebbaki, Salwa Sarah, et al.
Publicado: (2012)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Plasma glutamine after acute or elective admission on the ICU
por: Buter, H, et al.
Publicado: (2015)

Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8
por: Aizawa, Junichi, et al.
Publicado: (2010)

Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α
por: Sasaki, Makoto, et al.
Publicado: (2005)

Role of parenteral glutamine supplementation on patient outcome in the surgical ICU
por: Aboelmagd, R, et al.
Publicado: (2009)

Glutamine levels in patients with traumatic brain injury and subarachnoid haemorrhage
por: van Rosmalen, J, et al.
Publicado: (2015)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

Preoperative nutrition support with or without glutamine can reduce ICU admissions
por: Asprer, J, et al.
Publicado: (2006)

Effect of enteral and/or parenteral glutamine supplementation on mortality and morbidity in the critically ill
por: Sungurtekin, H, et al.
Publicado: (2014)

Glutamine administration in sepsis: enteral, parenteral or both? Experimental study in swine
por: Stavrou, G, et al.
Publicado: (2015)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
por: Ye, Jinjun, et al.
Publicado: (2015)

Comparison of the effects of intravenous, enteral and enteral + intravenous supply of glutamine on malnutrition in sepsis
por: Koksal, G, et al.
Publicado: (2011)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Validation of a point-of-care instrument for bedside glutamine screening in the intensive care unit
por: Pettersson, L, et al.
Publicado: (2015)

Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)

The antidiabetic drug troglitazone protects against PrP (106–126)-induced neurotoxicity via the PPARγ-autophagy pathway in neuronal cells
por: Moon, Ji-Hong, et al.
Publicado: (2021)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
por: Davies, Gerald F, et al.
Publicado: (2009)

Molecular mechanism of glutamine induction of HSP70 involves activation of the O-linked-N-acetylglucosamine pathway in murine embryonic fibroblast cells
por: Hamiel, C, et al.
Publicado: (2007)

Post-operative immune suppression is reversible with interferon gamma and independent of IL-6 pathways
por: Longbottom, ER, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qgt45rae4etro090c2ucaakr34